http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Nomura, Akihiro,Won, Hong-Hee,Khera, Amit V.,Takeuchi, Fumihiko,Ito, Kaoru,McCarthy, Shane,Emdin, Connor A.,Klarin, Derek,Natarajan, Pradeep,Zekavat, Seyedeh M.,Gupta, Namrata,Peloso, Gina M.,Borecki, Grune & Stratton 2017 Circulation research Vol.121 No.1
<P>Conclusions: Compared with noncarriers, carriers of PTV at CETP displayed higher high-density lipoprotein cholesterol, lower low-density lipoprotein cholesterol, lower triglycerides, and lower risk for CHD.</P>
Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels
CHARGE-Heart Failure Consortium,CARDIoGRAM Exome Consortium,Emdin, C.A.,Khera, A.V.,Natarajan, P.,Klarin, D.,Won, H.H.,Peloso, G.M.,Stitziel, N.O.,Nomura, A.,Zekavat, S.M.,Bick, A.G.,Gupta, N.,Asselta Elsevier Inc. 2016 Journal of the American College of Cardiology Vol.68 No.25
<P>CONCLUSIONS Beyond CHD, genetically lowered Lp(a) levels are associated with a lower risk of peripheral vascular disease, stroke, heart failure, and aortic stenosis. As such, pharmacological lowering of plasma Lp(a) may influence a range of atherosclerosis-related diseases. (C) 2016 by the American College of Cardiology Foundation.</P>